Search research articles
Contact Us
Filters
Showing results (41-50 of 95) with videos related to
Page
of 10
Sort By:
Haematologica
|
October 2, 2009
Marked therapeutic efficacy of a novel polyethylene glycol-SN38 conjugate, EZN-2208, in xenograft models of B-cell non-Hodgkin's lymphoma
Puja Sapra, Patricia Kraft, Mary Mehlig, et al.
Cancer Research
|
December 29, 1998
Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C
S K Rabindran, H He, M Singh, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 10, 2004
Syntheses and EGFR kinase inhibitory activity of 6-substituted-4-anilino [1,7] and [1,8] naphthyridine-3-carbonitriles
Allan Wissner, Philip R Hamann, Ramaswamy Nilakantan, et al.
Cancer Cell
|
September 12, 2021
Anti-spike antibody response to SARS-CoV-2 booster vaccination in patients with B cell-derived hematologic malignancies
Lee M Greenberger, Larry A Saltzman, Jonathon W Senefeld, et al.
Cancer Cell
|
July 31, 2021
Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies
Lee M Greenberger, Larry A Saltzman, Jonathon W Senefeld, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2008
Novel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin-11-refractory model
Puja Sapra, Hong Zhao, Mary Mehlig, et al.
Molecular Pharmacology
|
August 1, 1994
Localization of the forskolin labeling sites to both halves of P-glycoprotein: similarity of the sites labeled by forskolin and prazosin
D I Morris, L M Greenberger, E P Bruggemann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2006
Preclinical pharmacologic evaluation of MST-997, an orally active taxane with superior in vitro and in vivo efficacy in paclitaxel- and docetaxel-resistant tumor models
Deepak Sampath, Lee M Greenberger, Carl Beyer, et al.
Blood Cancer Discovery
|
November 15, 2021
How to Provide the Needed Protection from COVID-19 to Patients with Hematologic Malignancies
Antoni Ribas, Madhav V Dhodapkar, Katie M Campbell, et al.
Biochemistry
|
November 3, 2004
Tumor cells resistant to a microtubule-depolymerizing hemiasterlin analogue, HTI-286, have mutations in alpha- or beta-tubulin and increased microtubule stability
Marianne S Poruchynsky, Jong-Hyeok Kim, Eva Nogales, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 95) with videos related to
Sort By:
Page
of 10
Haematologica
|
October 2, 2009
Marked therapeutic efficacy of a novel polyethylene glycol-SN38 conjugate, EZN-2208, in xenograft models of B-cell non-Hodgkin's lymphoma
Puja Sapra, Patricia Kraft, Mary Mehlig, et al.
Cancer Research
|
December 29, 1998
Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C
S K Rabindran, H He, M Singh, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 10, 2004
Syntheses and EGFR kinase inhibitory activity of 6-substituted-4-anilino [1,7] and [1,8] naphthyridine-3-carbonitriles
Allan Wissner, Philip R Hamann, Ramaswamy Nilakantan, et al.
Cancer Cell
|
September 12, 2021
Anti-spike antibody response to SARS-CoV-2 booster vaccination in patients with B cell-derived hematologic malignancies
Lee M Greenberger, Larry A Saltzman, Jonathon W Senefeld, et al.
Cancer Cell
|
July 31, 2021
Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies
Lee M Greenberger, Larry A Saltzman, Jonathon W Senefeld, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2008
Novel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin-11-refractory model
Puja Sapra, Hong Zhao, Mary Mehlig, et al.
Molecular Pharmacology
|
August 1, 1994
Localization of the forskolin labeling sites to both halves of P-glycoprotein: similarity of the sites labeled by forskolin and prazosin
D I Morris, L M Greenberger, E P Bruggemann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2006
Preclinical pharmacologic evaluation of MST-997, an orally active taxane with superior in vitro and in vivo efficacy in paclitaxel- and docetaxel-resistant tumor models
Deepak Sampath, Lee M Greenberger, Carl Beyer, et al.
Blood Cancer Discovery
|
November 15, 2021
How to Provide the Needed Protection from COVID-19 to Patients with Hematologic Malignancies
Antoni Ribas, Madhav V Dhodapkar, Katie M Campbell, et al.
Biochemistry
|
November 3, 2004
Tumor cells resistant to a microtubule-depolymerizing hemiasterlin analogue, HTI-286, have mutations in alpha- or beta-tubulin and increased microtubule stability
Marianne S Poruchynsky, Jong-Hyeok Kim, Eva Nogales, et al.
Page
of 10